BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Hepatitis C virus
1
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
12/31/2021 12:21:18 PM | Browse: 61 | Download: 54
2
Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?
10/27/2021 7:14:11 AM | Browse: 39 | Download: 78
3
In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?
10/22/2021 1:53:28 PM | Browse: 64 | Download: 138
4
Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in Cambodia
9/22/2021 8:09:41 AM | Browse: 85 | Download: 98
5
Hepatitis C virus failure to treatment: Clinical utility of testing resistance associated substitutions
9/22/2021 8:09:41 AM | Browse: 75 | Download: 124
6
Screening and prevention of hepatitis C virus reactivation during chemotherapy
8/18/2021 8:08:20 AM | Browse: 136 | Download: 105
7
Neurological and psychiatric effects of hepatitis C virus infection
8/4/2021 7:56:20 AM | Browse: 82 | Download: 123
8
New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
8/4/2021 7:56:20 AM | Browse: 77 | Download: 85
9
Cellular factors involved in the hepatitis C virus life cycle
7/26/2021 11:20:59 AM | Browse: 96 | Download: 209
10
Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use
6/18/2021 5:06:16 AM | Browse: 99 | Download: 162
11
Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatched
5/27/2021 9:41:33 AM | Browse: 116 | Download: 184
12
Cascade of care for children and adolescents with chronic hepatitis C
3/25/2021 11:42:15 AM | Browse: 127 | Download: 131
13
Genotype 3-hepatitis C virus’ last line of defense
3/17/2021 6:19:34 AM | Browse: 155 | Download: 282
14
Histopathology and predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy
1/29/2021 7:57:41 AM | Browse: 162 | Download: 285
15
Human hepatitis viruses-associated cutaneous and systemic vasculitis
12/30/2020 1:59:10 PM | Browse: 217 | Download: 238
16
Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis?
11/25/2020 2:44:05 PM | Browse: 330 | Download: 305
17
Associations of content and gene polymorphism of macrophage inhibitory factor-1 and chronic hepatitis C virus infection
11/6/2020 7:36:12 AM | Browse: 191 | Download: 456
18
Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations
10/24/2020 2:27:21 AM | Browse: 263 | Download: 488
19
Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history
10/24/2020 2:27:20 AM | Browse: 220 | Download: 242
20
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
10/14/2020 11:33:23 AM | Browse: 213 | Download: 429
21
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over
9/21/2020 4:02:08 PM | Browse: 207 | Download: 348
22
Liver transplantation and aging
9/16/2020 1:57:57 PM | Browse: 293 | Download: 322
23
Management of hepatitis C in children and adolescents during COVID-19 pandemic
8/25/2020 9:16:00 AM | Browse: 250 | Download: 439
24
Accelerating the elimination of hepatitis C in Kuwait: An expert opinion
8/14/2020 12:33:31 PM | Browse: 264 | Download: 347
25
Facial and bilateral lower extremity edema due to drug-drug interactions in a patient with hepatitis C virus infection and benign prostate hypertrophy: A case report
8/6/2020 9:52:06 AM | Browse: 282 | Download: 364
26
M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
6/6/2020 2:43:56 PM | Browse: 409 | Download: 529
27
Pathological characterization of occult hepatitis B virus infection in hepatitis C virus-associated or non-alcoholic steatohepatitis-related hepatocellular carcinoma
4/28/2020 11:19:00 AM | Browse: 344 | Download: 419
28
Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma
4/7/2020 2:46:34 PM | Browse: 425 | Download: 658
29
Successful liver transplantation for acute sickle cell intrahepatic cholestasis: A case report and review of the literature
3/24/2020 5:16:35 AM | Browse: 346 | Download: 412
30
Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms
12/28/2019 9:29:28 AM | Browse: 379 | Download: 690
31
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study
10/28/2019 11:23:12 AM | Browse: 442 | Download: 730
32
Exploring the hepatitis C virus genome using single molecule real-time sequencing
8/28/2019 12:23:27 PM | Browse: 436 | Download: 397
33
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
8/7/2019 7:09:17 AM | Browse: 477 | Download: 673
34
Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions
8/7/2019 7:09:17 AM | Browse: 516 | Download: 568
35
Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals
6/6/2019 5:44:00 PM | Browse: 468 | Download: 758
36
Management of betablocked patients after sustained virological response in hepatitis C cirrhosis
6/6/2019 8:31:40 AM | Browse: 441 | Download: 752
37
Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus co-infection in human immunodeficiency virus infected individuals
5/27/2019 8:24:36 AM | Browse: 562 | Download: 426
38
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus
3/20/2019 5:32:10 AM | Browse: 649 | Download: 856
39
Necrolytic acral erythema in a human immunodeficiency virus/hepatitis C virus coinfected patient: A case report
2/26/2019 11:29:06 AM | Browse: 522 | Download: 573
40
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
1/26/2019 11:40:14 AM | Browse: 598 | Download: 613
41
Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma
1/7/2019 10:39:41 AM | Browse: 556 | Download: 603
42
Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
12/27/2018 9:28:07 AM | Browse: 489 | Download: 612
43
Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions
12/6/2018 1:35:45 PM | Browse: 652 | Download: 693
44
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
11/27/2018 1:56:41 PM | Browse: 555 | Download: 887
45
Mononuclear phagocyte system in hepatitis C virus infection
11/27/2018 5:55:53 AM | Browse: 506 | Download: 541
46
Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
11/7/2018 2:30:08 AM | Browse: 541 | Download: 626
47
Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
10/26/2018 11:38:21 AM | Browse: 466 | Download: 661
48
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
10/12/2018 5:32:21 AM | Browse: 741 | Download: 601
49
Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
9/27/2018 9:38:46 AM | Browse: 637 | Download: 753
50
Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
9/27/2018 9:38:46 AM | Browse: 514 | Download: 534
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345